Home/Filings/4/0001578852-26-000006
4//SEC Filing

Boulding Mark Elliott 4

Accession 0001578852-26-000006

CIK 0001070081other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 5:20 PM ET

Size

14.9 KB

Accession

0001578852-26-000006

Insider Transaction Report

Form 4
Period: 2026-01-08
Boulding Mark Elliott
EXEC. VP AND CLO
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-01-08$76.56/sh2,482$190,022115,177 total
  • Sale

    Common Stock

    [F1][F3]
    2026-01-08$77.07/sh265$20,424114,912 total
  • Sale

    Common Stock

    [F4]
    2026-01-08$76.45/sh1,286$98,315113,626 total
  • Sale

    Common Stock

    [F1][F5]
    2026-01-09$77.46/sh1,521$117,817112,105 total
  • Sale

    Common Stock

    [F1][F6]
    2026-01-09$78.71/sh686$53,995111,419 total
  • Sale

    Common Stock

    [F1][F7]
    2026-01-09$79.52/sh107$8,509111,312 total
Footnotes (7)
  • [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.
  • [F2]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.95 to $76.92 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F3]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.99 to $77.23 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F4]Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs.
  • [F5]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.12 to $78.08 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F6]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.23 to $79.21 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F7]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.35 to $79.60 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Signature
/s/ Avraham S. Adler, Attorney-in-Fact|2026-01-12

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

Entity typeother

Related Parties

1
  • filerCIK 0001578852

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:20 PM ET
Size
14.9 KB